Analyst Alec Stranahan works at BAML and is covering the the Healthcare sector with 31 price targets and ratings documented since 2018 spanning on 5 stocks.
Alec Stranahan's average stock forecast success ratio is 30% with an average time for price targets to be met of 25 days.
Most recent stock forecast was given on YMAB, Y-mAbs Therapeutics, Inc at 15-May-2023.
Analyst best performing recommendations are on TGTX (TG THERAPEUTICS, INC).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS, INC) at 5/20/2022. The price target of $5 was fulfilled within 4 days with a profit of $0.39 (7.24%) receiving and performance score of 18.09.
Average potential price target upside
Currently, out of the existing stock ratings of Alec Stranahan - 2 which are a Hold (66.67%), 1 which are a Buy (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
6
$4.28 (248.84%)
2 months 27 days ago
0/2 (0%)
$4.95 (181.30%)
Hold
16
6 months 26 days ago
0/2 (0%)
$9.43 (156.93%)
Buy
6
$4.28 (248.84%)
21
6 months 26 days ago
2/12 (16.67%)
$27.38 (137.29%)
48
Buy
15
$13.28 (772.09%)
19
9 months 7 days ago
1/5 (20%)
$21.66 (147.05%)
184
Sell
7
$5.28 (306.98%)
10
1 years 6 months 13 days ago
3/6 (50%)
$7.55 (23.50%)
55
